NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Michelle Senchyna, PhD, vice president of clinical development and medical affairs at Aerie, discusses phase 2b study results for AR-15512 in dry eye disease.
Uncategorized
VIDEO: AR-15512 shows promise for dry eye disease in phase 2b study